Coherus BioSciences Inc (CHRS)
2.125
-0.04
(-2.07%)
USD |
NASDAQ |
May 17, 16:00
2.125
0.00 (0.00%)
After-Hours: 20:00
Coherus BioSciences Gross Profit Margin (Quarterly): 55.12% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 55.12% |
December 31, 2023 | 7.60% |
September 30, 2023 | 56.14% |
June 30, 2023 | 57.68% |
March 31, 2023 | 47.98% |
December 31, 2022 | 68.68% |
September 30, 2022 | 22.43% |
June 30, 2022 | 81.25% |
March 31, 2022 | 84.41% |
December 31, 2021 | 83.50% |
September 30, 2021 | 74.21% |
Date | Value |
---|---|
June 30, 2021 | 80.95% |
March 31, 2021 | 90.95% |
December 31, 2020 | 89.43% |
September 30, 2020 | 92.07% |
June 30, 2020 | 92.53% |
March 31, 2020 | 94.10% |
December 31, 2019 | 93.70% |
September 30, 2019 | 94.23% |
June 30, 2019 | 99.28% |
March 31, 2019 | 94.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
7.60%
Minimum
Dec 2023
99.28%
Maximum
Jun 2019
73.31%
Average
82.38%
Median
Gross Profit Margin (Quarterly) Benchmarks
AbbVie Inc | 66.74% |
Inovio Pharmaceuticals Inc | -- |
Nektar Therapeutics | 60.56% |
Avid Bioservices Inc | 7.05% |
Stereotaxis Inc | 57.65% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -10.41% |
Return on Invested Capital | -18.71% |
Operating Margin (Quarterly) | -55.18% |
Return on Net Operating Assets | -18.48% |